Publication | Closed Access

Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial

VaccinationVaccine SafetyVaccinologyOpen-label TrialVaccine DevelopmentImmunologyVaccine EfficacyInfluenza VaccineHealthy AdultsMedicinePhase I/iiInfluenza Vaccines